News Website

Serum-derived small extracellular vesicles as biomarkers for predicting pregnancy and delivery on assisted reproductive technology in patients with endometriosis - Frontiers

Serum-derived small extracellular vesicles as biomarkers for predicting pregnancy and delivery on assisted reproductive technology in patients with endometriosis Frontiers

Published: Dec. 18, 2024, 9:35 p.m.

Read Full Article

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today

Published: Dec. 18, 2024, 8:16 p.m.

Read Full Article

Married at First Sight UK's Lacey got candid about her health - MSN

Married at First Sight UK's Lacey got candid about her health MSN

Published: Dec. 18, 2024, 1:24 p.m.

Read Full Article

Hampshire fire service faces £6m deficit in 2025 - Bordon Herald

Hampshire fire service faces £6m deficit in 2025 Bordon Herald

Published: Dec. 18, 2024, 11:54 a.m.

Read Full Article

Hampshire fire service faces £6m deficit in 2025 - Liphook Herald

Hampshire fire service faces £6m deficit in 2025 Liphook Herald

Published: Dec. 18, 2024, 11:53 a.m.

Read Full Article

Hampshire fire service faces £6m deficit in 2025 - Alton Herald

Hampshire fire service faces £6m deficit in 2025 Alton Herald

Published: Dec. 18, 2024, 11:52 a.m.

Read Full Article

Pelvic pain and what to do about it - Sunbury Macedon Ranges Star Weekly

Pelvic pain and what to do about it Sunbury Macedon Ranges Star Weekly

Published: Dec. 13, 2024, 10:59 a.m.

Read Full Article

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial BioSpace

Published: Dec. 12, 2024, 11:25 p.m.

Read Full Article

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.

Read Full Article

Laura Barlow: Face-to-face GP appointments petition hits 100,000 - BBC.com

Laura Barlow: Face-to-face GP appointments petition hits 100,000 BBC.com

Published: Dec. 9, 2024, 8 p.m.

Read Full Article

Latest Articles

Serum-derived small extracellular vesicles as biomarkers for predicting pregnancy and delivery on assisted reproductive technology in patients with endometriosis - Frontiers

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Married at First Sight UK's Lacey got candid about her health - MSN

Hampshire fire service faces £6m deficit in 2025 - Bordon Herald

Hampshire fire service faces £6m deficit in 2025 - Liphook Herald

Hampshire fire service faces £6m deficit in 2025 - Alton Herald

Pelvic pain and what to do about it - Sunbury Macedon Ranges Star Weekly

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

Laura Barlow: Face-to-face GP appointments petition hits 100,000 - BBC.com

Subscribe to Our Newsletter